Top Markets
Coin of the day
Purple Biotech Ltd. Purple Biotech Ltd.

Purple Biotech Ltd.

PPBT
Rangering i aksjer #40643
Purple Biotech Ltd., a clinical-stage company, is focused on creating therapies... Purple Biotech Ltd., a clinical-stage company, is focused on creating therapies for cancer patients in the United States, specifically addressing challenges like tumor immune evasion and drug resistance. Its diverse oncology pipeline includes CM24, a humanized monoclonal antibody that targets and blocks carcinoembryonic antigen related cell adhesion molecule 1 (CEACAM1). Currently in Phase 2 clinical trials, CM24 is being investigated as a combination therapy with anti-PD-1 checkpoint inhibitors for treating pancreatic ductal adenocarcinoma. Another candidate is NT219, a small molecule compound in Phase 1/2 clinical trials, which functions by inhibiting insulin receptor substrate 1 and 2 (IRS1/2) and signal transducer and activator of transcription (STAT). This compound is being developed for recurrent and/or metastatic squamous cell carcinoma of the head and neck, or colorectal adenocarcinoma. Furthermore, IM1240, a multi-valent antibody designed to activate an anti-tumoral immune response against 5T4-positive tumors, is in its preclinical stage. The company has established significant collaborations, including an agreement with Bristol Myers Squibb Company for Phase 2 clinical trials to assess CM24 in combination with the PD-1 inhibitor nivolumab and chemotherapy, as well as a partnership with Mor Research Applications. Formerly known as Kitov Pharma Ltd., the company adopted the name Purple Biotech Ltd. in December 2020 and is headquartered in Rehovot, Israel.
Aksjekurs
$0.00323826
Sist synkronisert: 2026-08-12
Markedsverdi
$104.81K
Endring (1 dag)
0.00%
Endring (1 år)
-70.42%
Land
IL
Handel Purple Biotech Ltd. (PPBT)

Kategori

Pris PPBT pris med markedsverdi på B
Purple Biotech Ltd. Purple Biotech Ltd.
PPBT
$0.00323826
Markedsverdi av Purple Biotech Ltd.(PPBT)
Markedsverdi: $104.81K
Per August 2026 har Purple Biotech Ltd. en markedsverdi på $104.81K. Dette gjør Purple Biotech Ltd. til det 40643rd mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Purple Biotech Ltd. fra 2002 til 2026
PPBT sammenlignet med topp 5 mest populære stocks
Pris på PPBT Eiendel B Markedsverdi for B Resultater
Purple Biotech Ltd. Purple Biotech Ltd.
$168,876 $104.81K
$5.466T +5,215,023,849.19%
Purple Biotech Ltd. Purple Biotech Ltd.
$137,731 $104.81K
$4.458T +4,253,248,315.50%
Purple Biotech Ltd. Purple Biotech Ltd.
$128,998 $104.81K
$4.175T +3,983,544,228.68%
Purple Biotech Ltd. Purple Biotech Ltd.
$113,349 $104.81K
$3.669T +3,500,297,589.27%
Purple Biotech Ltd. Purple Biotech Ltd.
$88,162.17 $104.81K
$2.853T +2,722,513,793.08%